Files
Download Full Text (360 KB)
Contents
- Pancreatic Cancer: The Prognosis Is Changing
- Delivering “The Guardian of the Genome”
- House Call: “Seeing” Cancer from the Outside
- Catching Pancreatic Cancer Early
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
2008
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Abbruzzese, James L.; Fleming, Jason B.; McConkey, David J.; Gallick, Gary E.; Logsdon, Craig; Roth, Jack A.; Pancreatic Neoplasms; Pancreatic Neoplasms -- mortality; Gemcitabine; Genes, BRCA2; Neoplasm Micrometastasis; Neoadjuvant Therapy; Erlotinib Hydrochloride; Bevacizumab; Capecitabine; Everolimus; DNA Repair; iniparib; Benzamides; Drug Resistance; Clinical Trials as Topic; Proto-Oncogene Proteins c-met; Histone Deacetylase Inhibitors; cabozantinib; Vorinostat; Diagnostic Imaging; Radiography; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography; Genes, p53; Genetic Therapy; advexin; Viral Vaccines; Nanoparticle Drug Delivery System; ubiquitin precursor; Survival Rate.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Munch, Joe and Patterson, Sunita, "OncoLog Volume 53, Number 10, October 2008" (2008). OncoLog MD Anderson's Report to Physicians (All issues). 170.
https://openworks.mdanderson.org/oncolog/170
Conditions Governing Access
Open
